Surgical Outcomes after Pulmonary Resection for Non–Small Cell Lung Cancer with Localized Pleural Seeding First Detected during Surgery
11 June 2015
27 August 2015
15 December 2015 (eFirst)
Objectives Curative resection is not indicated for non–small cell lung cancer (NSCLC) with pleural seeding, which is classified as stage IV (M1a) disease. However, some patients with a presumably resectable main tumor are diagnosed with localized pleural seeding during surgery.
Methods A retrospective analysis was performed of 3,975 patients who underwent surgery for NSCLC from 2000 to 2011. Among these cases, 78 (2.0%) patients had unexpected pleural seeding detected during surgery. Exploration with pleural biopsy was performed in 42 of these patients (exploration-only group) and pulmonary resection, including for the main tumor, was performed in 36 cases (resection group; sublobar resection in 12, lobectomy in 21, and pneumonectomy in 3 patients). Survival and cancer progression rates were estimated using the Kaplan–Meier method. Cox proportional hazard regression was used to evaluate prognostic factors associated with survival.
Results Adenocarcinoma was the predominant histological type in both the exploration and resection groups (88.1 and 86.1%, respectively). Epidermal growth factor receptor expression was detected in 22 (52.4%) patients of the exploration group and 21 (58.3%) patients of the resection group. Baseline characteristics including age, sex, comorbidity, pulmonary function, and clinical T/N status were not significantly different between the two groups. There were no postoperative deaths in either group but postoperative complications occurred in two (4.8%) patients of the exploration group and three (8.3%) patients of the resection group. The overall 3- and 5-year survival rates in the exploration group were 41.1 and 15.2%, respectively, with a median survival time (MST) of 33 months, whereas they were 66.7 and 42.7%, respectively, in the resection group, with a 52-month MST (p = 0.012). Local and regional progression–free rates were significantly different (p < 0.001 and p = 0.029, respectively) between groups, whereas no difference was seen in the distant metastasis rates (p = 0.957). In multivariate survival analysis, surgical resection was the only significant prognostic factor (p = 0.01).
Conclusions Pulmonary resection including the main tumor, regardless of resection extent, may increase long-term survival for NSCLC patients with localized pleural seeding first detected during surgery, without a significant increase in hospital mortality or morbidity.
Both Drs Jae Kwang Yun and Mi-Ae Kim contributed equally to this work.
- 1 Akaogi E, Mitsui K, Onizuka M, Ishikawa S, Tsukada H, Mitsui T. Pleural dissemination in non-small cell lung cancer: results of radiological evaluation and surgical treatment. J Surg Oncol 1994; 57 (01) 33-39
- 2 van der Drift MA, Karim-Kos HE, Siesling S. , et al. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol 2012; 7 (02) 291-298
- 3 Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009; 15 (01) 4-9
- 4 Sobin LH, Gospodarowicz MK, Wittekind C. Lung and pleural tumours. In: TNM Classification of Malignant Tumours. 7th ed. Oxford: Wiley-Blackwell; 2009: 138-146
- 5 Ou SH, Zell JA. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol 2008; 3 (03) 216-227
- 6 Reyes L, Parvez Z, Regal AM, Takita H. Neoadjuvant chemotherapy and operations in the treatment of lung cancer with pleural effusion. J Thorac Cardiovasc Surg 1991; 101 (05) 946-947
- 7 Ichinose Y, Tsuchiya R, Koike T. , et al; Japan Oncology Group. Prognosis of resected non-small cell lung cancer patients with carcinomatous pleuritis of minimal disease. Lung Cancer 2001; 32 (01) 55-60
- 8 Sawabata N, Matsumura A, Motohiro A. , et al; Japanese National Chest Hospital Study group for Lung Cancer. Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumor resection beneficial for prognosis?. Ann Thorac Surg 2002; 73 (02) 412-415
- 9 Riquet M, Foucault C, Souilamas F. Lung cancer with pleural dissemination: why not operation?. Ann Thorac Surg 2002; 74 (05) 1750 , author reply 1750
- 10 Yokoi K, Matsuguma H, Anraku M. Extrapleural pneumonectomy for lung cancer with carcinomatous pleuritis. J Thorac Cardiovasc Surg 2002; 123 (01) 184-185
- 11 Ohta Y, Shimizu Y, Matsumoto I, Tamura M, Oda M, Watanabe G. Retrospective review of lung cancer patients with pleural dissemination after limited operations combined with parietal pleurectomy. J Surg Oncol 2005; 91 (04) 237-242
- 12 Pagan V, Fontana P, Zaccaria A, Lo Giudice F, Oniga F. Surgical outcome of lung cancer patients with carcinomatous pleuritis. Chir Ital 2005; 57 (06) 703-708
- 13 Mordant P, Arame A, Foucault C, Dujon A, Le Pimpec Barthes F, Riquet M. Surgery for metastatic pleural extension of non-small-cell lung cancer. Eur J Cardiothorac Surg 2011; 40 (06) 1444-1449
- 14 Go T, Misaki N, Matsuura N, Chang SS, Tarumi S, Yokomise H. Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer. Surg Today 2015; 45 (02) 197-202
- 15 Lynch TJ, Bell DW, Sordella R. , et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350 (21) 2129-2139
- 16 Paez JG, Jänne PA, Lee JC. , et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304 (5676): 1497-1500
- 17 Pao W, Miller V, Zakowski M. , et al. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 2004; 101 (36) 13306-13311
- 18 Miura T, Shimada T, Tanaka K, Chujo M, Uchida Y. Lymphatic drainage of carbon particles injected into the pleural cavity of the monkey, as studied by video-assisted thoracoscopy and electron microscopy. J Thorac Cardiovasc Surg 2000; 120 (03) 437-447
- 19 Ichinose Y, Tsuchiya R, Koike T. , et al; Japan Clinical Oncology Group. The prognosis of patients with non-small cell lung cancer found to have carcinomatous pleuritis at thoracotomy. Surg Today 2000; 30 (12) 1062-1066